Telethon Foundation

Company snapshot

Telethon Foundation maintains 162 tracked programs across Mantle Cell Lymphoma, Colon cancer, colorectal cancer, NSCLC non-small cell lung cancer, Follicular lymphoma, cardiac amyloidosis, Prostate Cancer, Chronic Myeloid Leukemia (CML) in Chronic Phase (CP), newly diagnosed non-M3 FLT3-positive acute myeloid leukemia, endometrial cancer, ER-positive, HER2-negative Early breast cancer, Very High-R

• 162 active pipeline program(s) linked via ClinicalTrials.gov.
• 162 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Telethon Foundation. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Telethon Foundation.

1. Jun 8, 2026 Clinical update

   CABOMETYX for bladder carcinoma of urothelial… — Phase 2

2. Jun 8, 2026 Clinical update

   REPRINT — Phase 2

3. Jun 8, 2026 Clinical update

   PreSave — Phase 2

4. Jun 8, 2026 Clinical update

   MITO 35a — Phase 2

5. Jun 8, 2026 Clinical update

   GIM35-RIBOSIL — Phase 2

View all clinical trial activity →

• What is Telethon Foundation?

  Fondazione Telethon ETS is a pharma organization headquartered in EU. Primary therapeutic focus areas include Mantle Cell Lymphoma, Colon cancer, colorectal cancer, NSCLC non-small cell lung cancer, Follicular lymphoma. NovaPharmaNews links 162 clinical program(s), 0 drug profile

• Is Telethon Foundation publicly traded?

  Telethon Foundation appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Telethon Foundation develop or market?

  We link 285 drug profile(s) where Telethon Foundation is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/fondazione-telethon-ets#company-drugs.

• What are the latest developments for Telethon Foundation?

  In the last 12 months our linked public records show 162 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Telethon Foundation focus on?

  Telethon Foundation focuses on Mantle Cell Lymphoma, Colon cancer, colorectal cancer based on our analysis of their pipeline programs and drug development activities.